Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 4:43 pm Unchanged | 2025-12-31 | 13G | Inovio Pharmaceuticals, Inc. INO | Alyeska Investment Group L.P. | 4,000,000 5.990% | 0 (Unchanged) | Filing History |
| 2026-01-30 2:20 pm Purchase | 2025-12-31 | 13G | Inovio Pharmaceuticals, Inc. INO | VANGUARD GROUP INC | 3,315,579 4.960% | 1,286,620 (+63.41%) | Filing History |
| 2025-12-08 11:45 am Purchase | 2025-11-28 | 13G | Inovio Pharmaceuticals, Inc. INO | JANUS HENDERSON GROUP PLC JHG | 6,666,295 9.990% | 3,400,035 (+104.10%) | Filing History |
| 2025-12-05 2:03 pm Purchase | 2025-11-28 | 13G | Inovio Pharmaceuticals, Inc. INO | FMR LLC | 9,846,664 14.800% | 9,846,664 (New Position) | Filing History |
| 2025-11-14 8:01 pm Purchase | 2025-09-30 | 13G | Inovio Pharmaceuticals, Inc. INO | Alyeska Investment Group L.P. | 4,000,000 7.530% | 4,000,000 (New Position) | Filing History |
| 2025-11-14 10:34 am Purchase | 2025-09-30 | 13G | Inovio Pharmaceuticals, Inc. INO | JANUS HENDERSON GROUP PLC JHG | 3,266,260 6.200% | 3,266,260 (New Position) | Filing History |
| 2025-11-14 08:15 am Purchase | 2025-09-30 | 13G | Inovio Pharmaceuticals, Inc. INO | Deep Track Capital, LP | 1,314,796 2.410% | 1,314,796 (New Position) | Filing History |
| 2025-11-13 09:16 am Purchase | 2025-09-30 | 13G | Inovio Pharmaceuticals, Inc. INO | Adage Capital Management, L.P. | 5,517,650 9.990% | 5,517,650 (New Position) | Filing History |
| 2025-07-17 7:54 pm Sale | 2025-06-30 | 13G | Inovio Pharmaceuticals, Inc. INO | BlackRock Inc. BLK | 537,627 1.500% | -1,780,853 (-76.81%) | Filing History |
| 2025-05-14 4:10 pm Sale | 2025-03-31 | 13G | Inovio Pharmaceuticals, Inc. INO | Stonepine Capital Management, LLC | 1,434,997 3.800% | -481,669 (-25.13%) | Filing History |
| 2025-04-30 11:24 am Purchase | 2025-03-31 | 13G | Inovio Pharmaceuticals, Inc. INO | VANGUARD GROUP INC | 2,028,959 5.530% | 355,372 (+21.23%) | Filing History |
| 2025-04-17 09:35 am Purchase | 2025-03-31 | 13G | Inovio Pharmaceuticals, Inc. INO | BlackRock Inc. BLK | 2,318,480 6.300% | 409,969 (+21.48%) | Filing History |
| 2025-02-10 5:06 pm Purchase | 2024-12-31 | 13G | Inovio Pharmaceuticals, Inc. INO | HIGHBRIDGE CAPITAL MANAGEMENT LLC | 3,633,333 9.200% | 3,633,333 (New Position) | Filing History |
| 2025-02-05 5:28 pm Purchase | 2024-12-31 | 13G | Inovio Pharmaceuticals, Inc. INO | BlackRock Inc. BLK | 1,908,511 5.300% | 1,908,511 (New Position) | Filing History |
| 2025-01-30 9:58 pm Purchase | 2024-12-31 | 13G | Inovio Pharmaceuticals, Inc. INO | VANGUARD GROUP INC | 1,673,587 4.640% | 1,673,587 (New Position) | Filing History |
| 2024-12-23 8:08 pm Purchase | 2024-12-17 | 13G | Inovio Pharmaceuticals, Inc. INO | Stonepine Capital Management, LLC | 1,916,666 5.200% | 1,916,666 (New Position) | Filing History |
| 2024-11-08 2:17 pm Unchanged | 2024-11-08 | 13G | Inovio Pharmaceuticals, Inc. INO | BlackRock Inc. BLK | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-10-22 6:06 pm Unchanged | 2024-10-22 | 13G | Inovio Pharmaceuticals, Inc. INO | BlackRock Inc. BLK | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-04-26 4:01 pm Unchanged | 2024-04-26 | 13G | Inovio Pharmaceuticals, Inc. INO | Deep Track Capital, LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-02-13 5:06 pm Unchanged | 2024-02-13 | 13G | Inovio Pharmaceuticals, Inc. INO | VANGUARD GROUP INC | 0 0.000% | 0 (Unchanged) | Filing |